FDA's investigation into GLP-1s and suicidal thoughts has resulted in a tentative thumbs up for the drug class, with more assessments to come. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
